Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zsófia Borbála Dombi"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 5682 (2024)
Until the late 1800s, drug development was a chance finding based on observations and repeated trials and errors. Today, drug development must go through many iterations and tests to ensure it is safe, potent, and effective. This process is a long an
Externí odkaz:
https://doaj.org/article/3baddcdc69104e2db672dcc18a37f170
Autor:
Peter Falkai, Zsófia Borbála Dombi
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/d563389dcd83476e894d61e3912fd0ae
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundThe hierarchy of evidence coming from evidence-based medicine favors meta-analyses and randomized controlled trials over observational studies and clinical cases. Nonetheless, in the field of psychiatry, where conditions are much more compl
Externí odkaz:
https://doaj.org/article/ac2161dcd15a4aa2b81cc977d3654c05
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2022)
Although the optimal dosing of an antipsychotic medication is known to be essential in the long-term management of schizophrenia, in case of novel drugs such as cariprazine, determining the right dosing strategy is not that simple. Without decades of
Externí odkaz:
https://doaj.org/article/31cf5f0e6e544e1b89703b98f9c9a3d0
Autor:
Elmars Rancans, Péter Mátrai, Barbara Sebe, Zsófia Borbála Dombi, György Németh, Iveta Skrivele, Ágota Barabássy
Publikováno v:
International Clinical Psychopharmacology
Supplemental Digital Content is available in the text.
The aim of the study was to examine the effectiveness and safety of cariprazine in routine psychiatric settings on schizophrenia patients with negative symptoms who have been treated with an
The aim of the study was to examine the effectiveness and safety of cariprazine in routine psychiatric settings on schizophrenia patients with negative symptoms who have been treated with an
Autor:
Sebe, Barbara, Ágota, Barabássy, Krisztina, Buksa, István, Laszlovszky, Zsófia Borbála, Dombi, György, Németh, Peter, Falkai
Publikováno v:
Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata. 36(4)
People with schizophrenia often need long-term support in their everyday life. Thus, caregivers are vital factors to support their recovery and long-term functioning. In turn, however, the caregiver role is highly burdensome and may lead to severe di
Publikováno v:
Psychosis-Phenomenology, Psychopathology and Pathophysiology ISBN: 9781839690440
The aim of this chapter is to summarize the state-of-the-art knowledge of clinical staging in schizophrenia spectrum disorders. Clinical staging has been introduced to psychiatry in the past two decades. Its primary goal is to divide the course of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f52d9bda8d4e741fe5f21356b285a58
http://www.intechopen.com/articles/show/title/clinical-staging-in-schizophrenia-spectrum-disorders
http://www.intechopen.com/articles/show/title/clinical-staging-in-schizophrenia-spectrum-disorders
Publikováno v:
Expert Opinion on Pharmacotherapy. 23:1467-1468
In a recent issue of Expert Opinion on Pharmacotherapy (2021), Joshua T. Kantrowitz posed the important question ‘How do we address treating the negative symptoms of schizophrenia pharmacologically...
Publikováno v:
European Psychiatry, Vol 67 (2024)
Abstract Background Predominant negative symptoms (PNSs) in schizophrenia can affect the patients’ psychosocial functioning immensely and are less responsive to treatment than positive symptoms. Aims The aim of the study was to observe negative
Externí odkaz:
https://doaj.org/article/dd8f2fce4e5a4251b7d597d6128aedf3